The company said net income for Q4 2024 was $326 million ($1.34 per share), with a net income margin of 14.5%, up 190 basis points. The company cited a non-recurring gain on the remeasurement of its previously held equity interest in Idrica as a factor, and said adjusted net income was $287 million ($1.18 per share).

1. 01

   The company said net income for Q4 2024 was $326 million ($1.34 per share), with a net income margin of 14.5%, up 190 basis points. The company cited a non-recurring gain on the remeasurement of its previously held equity interest in Idrica as a factor, and said adjusted net income was $287 million ($1.18 per share).

2. 02

   Xylem said full-year revenue for 2024 was $8.6 billion, up 16% on a reported basis and 6% on an organic basis. Full-year earnings per share was $3.65, up 31%, and adjusted earnings per share was $4.27, up 13%.

3. 03

   The company said it provided full-year 2025 adjusted earnings per share guidance of $4.50 to $4.70, an adjusted EBITDA margin of approximately 21.3 to 21.8%, and a free cash flow margin of approximately 9 to 10%. It also said it declared a Q1 dividend of $0.40 per share, an increase of 11%.

4. 04

   The company reported net cash from operating activities of $1,263 million for the full year 2024 ($837 million in 2023), capital expenditures of $321 million and dividends paid of $350 million in the same period (in millions).

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.